Trending
Binance says 90% of assets from its $6.3B hack are now backed, with conditional withdrawal resumption planned for Sunday pending security clearance.
Rivian may be approaching a production inflection like Tesla’s Model 3 era, which drove a 1,364% stock climb in three years. The R2 model is central to that bet.
AI is eliminating routine entry-level tasks, leaving employers and educators scrambling to rebuild career development from scratch.
Israel’s election left no clear majority, triggering weeks of coalition talks. Netanyahu’s party claims the vote was stolen, deepening political and economic uncertainty.
Sprouts opened a record 15 stores last quarter but its existing locations are declining in sales. The stock dropped 19% after management guided for the trend to worsen.
Binance says 90% of assets from its $6.3B hack are now backed, with conditional withdrawal resumption planned for Sunday pending security clearance.
Israel’s election left no clear majority, triggering weeks of coalition talks. Netanyahu’s party claims the vote was stolen, deepening political and economic uncertainty.
Just In
Humanoid robots excel mechanically but struggle with memory and learning. That cognitive gap is now the key barrier to commercial deployment and real earnings potential.
AI is eliminating routine entry-level tasks, leaving employers and educators scrambling to rebuild career development from scratch.
PM Mark Carney says U.S.-Canada trade talks have intensified slightly, with Washington moving closer to Ottawa’s demands. Canada is holding firm on its position.
A fire broke out at a Quaker Oats plant in Cedar Rapids, Iowa at 4:45 p.m. No injuries were immediately reported. Cedar Rapids Fire Department responded.
Finance
Rivian may be approaching a production inflection like Tesla’s Model 3 era, which drove a 1,364% stock climb in three years. The R2 model is central to that bet.
Editor's Picks
Latest
Americans 65+ are now cosmetic surgery’s fastest-growing customers, reshaping clinic revenues and creating new investment opportunities in devices and injectables.

































